Pharma Fights Healthcare Cost-Containment Policies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Fights Healthcare Cost-Containment Policies
The ongoing economic crisis in Europe has accelerated healthcare cost-containment measures targeting the price of pharmaceuticals, but the pharma industry is not giving in without a fight.




References

The Guardian website, “The Euro Crisis is Over, Declares José Manuel Barroso,” http://www.guardian.co.uk, accessed 15 Jan. 2013.

Reuters website, “Europe Economic Recovery Seen Mid-2013 — ECB,” http://uk.reuters.com , accessed 15 Jan. 2013.

The Telegraph website, “Europe’s Bad Debts ‘Will Bite in 2013’,” www.telegraph.co.uk, accessed 15 Jan. 2013.

EFPIA website, “Letter from EFPIA President, Sir Andrew Witty, to European Heads of States and Governments,” http://www.efpia.eu, accessed 15 Jan. 2013.

Swiss Info, “Recession-Hit Nations Owe Pharma Firms Billions,” http://www.swissinfo.ch, accessed 15 Jan. 2013.

PharmaTimes website, “Drugmakers Tell Greece: “We’ll Cap your Medicines Bill,” http://www.pharmatimes.com, accessed 15 Jan. 2013.

Business Week website, “Spain Drugmakers Plan $7 Billion Unpaid-Bill Securitization,” http://www.businessweek.com, accessed 15 Jan. 2013.

Chicago Tribune, “Spain Coughs Up Billions to Keep Regions in Medicine,” http://articles.chicagotribune.com, accessed 15 Jan. 2013.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here